MX1 and respiratory tract infectious disorder: Similarly, the point-of-care assay FebriDx, combining the bacterially induced protein CRP and the virally induced protein myxovirus resistance protein 1 (MxA), showed good performance in both children and adults with upper respiratory infections [11,26].